Aardvark Therapeutics, Inc. — Form 8-K
Filed August 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-08-17 regarding Item 5.07 (Submission of Matters to a Vote of Security Holders), with period of report 2026-08-14. The filing does not disclose specific vote details, counterparties, dollar amounts, percentages, or share counts in the available text excerpts—only metadata and XBRL taxonomy documents are shown.
Why this rating
Routine stockholder vote disclosure; no material transaction, financial impact, or operational change disclosed. Standard periodic SEC filing.
Extracted items
See more from August 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.